PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 29 |
| 2009 | 30 |
| 2010 | 32 |
| 2011 | 45 |
| 2012 | 26 |
| 2013 | 21 |
| 2014 | 33 |
| 2015 | 25 |
| 2016 | 34 |
| 2017 | 20 |
| 2018 | 22 |
| 2019 | 17 |
| 2020 | 24 |
| 2021 | 26 |
| 2022 | 17 |
| 2023 | 9 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 5 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Behav Pharmacol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Acute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague-Dawley rats.
- Evans B, Acharya N, Brandl CG, Shealy EG, Nyland JE, Freet CS, Bunce SC, Grigson PS.
- Behav Pharmacol. Author manuscript. 2026 Jun 2;37(5):249-265. doi: 10.1097/FBP.0000000000000880.
- PMCID: PMC13573658
Evans B, et al.Behav Pharmacol. Author manuscript. 2026.PMCID: PMC13573658 -
Drug-specific effects of anxiety on high-dose oxycodone: age as a modifier for oxycodone response.
- Wang L, Chai W, Wang B, Ding Q, Chen Y, Zheng Q, Wang N, Guo Y.
- Behav Pharmacol. 2026 Aug 11;37(5):266-276. doi: 10.1097/FBP.0000000000000894.
- PMCID: PMC13541607
Wang L, et al.Behav Pharmacol. 2026.PMCID: PMC13541607 -
Using UAS-Gal4 designer receptors exclusively activated by designer drugs to elucidate nondopaminergic modulation of methamphetamine-induced locomotion in Drosophila.
- Hibicke M, Nichols CD.
- Behav Pharmacol. Author manuscript. 2025 Jul 8;36(6):415-428. doi: 10.1097/FBP.0000000000000843.
- PMCID: PMC12324162
Hibicke M, et al.Behav Pharmacol. Author manuscript. 2025.PMCID: PMC12324162 -
Delta opioid receptors on parvalbumin cells are necessary for the convulsant and anxiolytic effects of the delta agonist SNC80.
- Walicki MC, Mueller MR, Raigosa Garza N, Levitt ES, Traynor JR, Jutkiewicz EM, Birdsong WT.
- Behav Pharmacol. Author manuscript. 2026 May 29;37(4):139-149. doi: 10.1097/FBP.0000000000000882.
- PMCID: PMC13322383
Walicki MC, et al.Behav Pharmacol. Author manuscript. 2026.PMCID: PMC13322383 -
Teneurin C-terminal associated peptide-1 attenuates chronic stress in male rats.
- Mueller LE, Siemian JN, Lovejoy DA, Stein RB, Slee AM.
- Behav Pharmacol. 2026 Jul 1;37(4):180-186. doi: 10.1097/FBP.0000000000000886.
- PMCID: PMC13317898
Mueller LE, et al.Behav Pharmacol. 2026.PMCID: PMC13317898 -
The effects of high fat diet consumption on morphine-induced constipation.
- Beltran NM, Garcia TI, Naime GM, Minervini V, Serafine KM.
- Behav Pharmacol. Author manuscript. 2025 Apr 29;36(5):343-346. doi: 10.1097/FBP.0000000000000831.
- PMCID: PMC12226213
Beltran NM, et al.Behav Pharmacol. Author manuscript. 2025.PMCID: PMC12226213 -
Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure.
- Fitzgerald LR, Stanley NC, Guise JB, Cargile CS, Mancino MJ, Oliveto AH.
- Behav Pharmacol. Author manuscript. 2025 Apr 8;36(5):265-275. doi: 10.1097/FBP.0000000000000823.
- PMCID: PMC12226226
Fitzgerald LR, et al.Behav Pharmacol. Author manuscript. 2025.PMCID: PMC12226226 -
Naltrexone treatment improves anxiety- and depression-like behavior in alcohol-exposed mice.
- Yang S, Tong L, Zhang L, Cui R, Lyu X, He L, Liu H.
- Behav Pharmacol. 2026 Feb 26;37(2):117-125. doi: 10.1097/FBP.0000000000000876.
- PMCID: PMC12959587
Yang S, et al.Behav Pharmacol. 2026.PMCID: PMC12959587 -
Effect of acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, and estrus phase on cue- and drug-induced fentanyl seeking in female rats.
- Urbanik LA, Booth JL, Acharya NK, Evans BB, Grigson PS.
- Behav Pharmacol. Author manuscript. 2024 Dec 24;36(1):16-29. doi: 10.1097/FBP.0000000000000805.
- PMCID: PMC12013456
Urbanik LA, et al.Behav Pharmacol. Author manuscript. 2024.PMCID: PMC12013456 -
1,4-dihydroxy-2-naphthoic acid prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced motor function deficits.
- Madison CA, Debler RA, Gallegos PL, Hillbrick L, Chapkin RS, Safe S, Eitan S.
- Behav Pharmacol. Author manuscript. 2024 Dec 12;36(1):40-46. doi: 10.1097/FBP.0000000000000806.
- PMCID: PMC11781791
Madison CA, et al.Behav Pharmacol. Author manuscript. 2024.PMCID: PMC11781791